Loading organizations...
§ Private Profile · Hofwisenstrasse 50A, 8153 Rümlang, Switzerland
Nanoleq is a technology company.
Nanoleq develops critical components for smart textiles, enabling precise bio-signal monitoring directly from clothing. The company specializes in creating stretchable, conductive materials and integrated electronics, such as their ElectroSkin electrodes, that seamlessly integrate into fabrics. These advanced e-components facilitate the measurement of various physiological data, including electrocardiograms (ECG), electromyograms (EMG), and respiratory inductance plethysmography (RIP), without compromising comfort or flexibility.
The company was co-founded in 2017 by Vincent Martinez and Serge Weydert, both possessing strong technical pedigrees from ETH Zurich. Martinez, with a PhD in micro-technologies, aimed to develop products that enhance understanding of the human body, while Weydert, holding a PhD in Neuroscience and Microtechnology and experience as a previous founder, focused on delivering accurate personal health data. Their combined insight recognized the potential of integrating advanced sensing capabilities into everyday textiles.
Nanoleq supplies its innovative components to brands across several sectors, including medical wear, sportswear, general wellbeing products, and workwear. The company’s long-term vision is to decentralize the healthcare system by empowering individuals with the tools to continuously monitor their own health. This approach aims to provide proactive health insights and promote greater personal well-being through accessible and integrated smart textile technology.
Nanoleq has raised $13.0M across 1 funding round.
Nanoleq has raised $13.0M in total across 1 funding round.
Nanoleq has raised $13.0M across 1 funding round. Most recently, it raised $13.0M Series A in December 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 1, 2021 | $13M Series A | Capnamic Ventures | Aperiamventures, Bornschein & Keine Töchter, Coelius Capital, Iris Capital, Math Capital, Redalpine Venture Partners, SignalFire, Sommet AB, Summit Partners, Michael Halbherr, Oliver Pabst, Verve Ventures, Zürcher Kantonalbank | Announced |
Nanoleq has raised $13.0M in total across 1 funding round.
Nanoleq's investors include Capnamic Ventures, AperiamVentures, Bornschein & keine Töchter, Coelius Capital, Iris Capital, Math Capital, Redalpine Venture Partners, SignalFire, Sommet AB, Summit Partners, Michael Halbherr, Oliver Pabst.
Nanoleq is a Swiss technology company specializing in smart textile components, particularly soft sensors for real-time health monitoring. Founded in 2017 as a spin-off from ETH Zurich, it develops thin, stretchable sensors that integrate seamlessly into clothing to track vital signs like ECG, EMG, EEG, respiration, heart rate variability (HRV), and stress levels, while enabling painless electrical stimulation for applications such as EMS, FES, and NMES.[1][3][4] These components serve medical, sports, wellness, and workwear sectors, solving the problem of uncomfortable, non-washable wearables by providing dry, reliable, durable biosensing in everyday garments.[1][2][4] Nanoleq's growth includes raising CHF 1.1 million, scaling production to 250k pieces/year, achieving first 6-digit monthly revenues, expanding to 32 employees, opening a Berlin subsidiary, and launching products like the Oxa device for respiratory and cardiac monitoring.[2][3]
Nanoleq emerged in 2017 as a spin-off from the Swiss Federal Institute of Technology in Zurich (ETH Zurich), co-founded by Vincent Martinez (PhD in biosensors and bioelectronics, former ieLab researcher at ETH) and Serge Weydert (PhD in neuroscience from ETH).[1][3] The idea stemmed from their expertise in soft electronic materials, biological signal acquisition/processing, and textile engineering, aiming to enable seamless electronics integration into washable garments for health monitoring.[1][3][4] Early traction included pre-series A funding (convertible), producing the first 1,000 shirts, securing 10 customers, medtech and sportswear applications, acquiring production lines like ElectroSkin and PhantomTape, and recognitions such as TOP 100 Swiss Startup (multiple years), Innosuisse awards, and Venture Leaders.[3][4] Milestones like 6-digit monthly revenues and board additions (e.g., Michael Halbherr, ex-Nokia VP) fueled expansion.[3]
Nanoleq rides the smart textiles and wearable health tech wave, decentralizing healthcare from hospitals to daily life via preventive, long-term monitoring—aligning with post-pandemic shifts toward at-home vital tracking and personalized wellness.[2][4] Timing is ideal amid rising demand for non-invasive biosensors in aging populations, telehealth, and performance optimization, fueled by advances in flexible electronics and textile computing.[1][2] Market forces like medical device validation, sustainability (washable/durable), and expansion into Europe/Middle East via partnerships favor it.[2][3] As a pioneer, Nanoleq influences the ecosystem by setting standards for health-monitoring textiles, enabling brands in medtech/sports, and accelerating adoption through ETH-rooted innovation.[1][3][4]
Post-2024 acquisition by Myant (Toronto-based textile computing leader), Nanoleq's sensors integrate into Myant's medical portfolio, supercharging global scale, EU/ME market entry, and clinical-grade devices for prevention-focused health.[2] Next steps likely include Oxa expansions, new sensors, and hybrid products blending Nanoleq's biosensing with Myant's platforms amid trends like AI-driven health data and sustainable wearables.[2][3] Its influence could evolve from component supplier to key enabler of "textile computing" ecosystems, empowering proactive health for all—reinforcing its Swiss-engineered foundation in reshaping monitoring from rigid devices to seamless fabrics.[1][2][4]